(PDF) Metronomic Cyclophosphamide Schedule-Dependence of

Metronomic Cyclophosphamide Schedule-Dependence of Innate Immune Cell Recruitment and Tumor Regression in an Implanted Glioma Model

Cancer Letters - Ireland

doi 10.1016/j.canlet.2014.07.033

Full Text

Open PDF

Abstract

Available in full text

Date

October 1, 2014

Authors

Junjie Wu

David J. Waxman

Publisher

Elsevier BV

Related search

CD8+ T Cell-Independent Tumor Regression Induced by Fc-Ox40l and Therapeutic Vaccination in a Mouse Model of Glioma

Journal of Immunology

Allergy

Immunology

2013

English

Anti-Tumor Innate Immunity Activated by Intermittent Metronomic Cyclophosphamide Treatment of 9L Brain Tumor Xenografts Is Preserved by Anti-Angiogenic Drugs That Spare VEGF Receptor 2

English

Targeting Tumor-Related Immunosuppression Using Metronomic Cyclophosphamide in Combination With Lenalidomide -New Mechanisms for Old Drugs

Chemotherapy: Open Access

2012

English

Toll-Like Receptors 2 and 9 Are Important for Innate Immune Cell Activation and Recruitment in Hypersensitivity Pneumonitis

English

Caveolin-2 Deficiency Induces a Rapid Anti-Tumor Immune Response Prior to Regression of Implanted Murine Lung Carcinoma Tumors

Scientific Reports

Multidisciplinary

2019

English

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

Clinical Cancer Research

Cancer Research

Oncology

2018

English

PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice With Tumoral T Lymphoblasts

Journal of Oncology

Oncology

2019

English

Innate Immune Defects in HIV Permissive Cell Lines

English

523 T-Cell Cytokines (IL-17 and IFN-γ) Exacerbates Innate Immune Responses in an Organotypic Human Psoriasis Tissue Model

Journal of Investigative Dermatology

English

Amanote Research

Metronomic Cyclophosphamide Schedule-Dependence of Innate Immune Cell Recruitment and Tumor Regression in an Implanted Glioma Model

Cancer Letters - Ireland

doi 10.1016/j.canlet.2014.07.033

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

CD8+ T Cell-Independent Tumor Regression Induced by Fc-Ox40l and Therapeutic Vaccination in a Mouse Model of Glioma

Anti-Tumor Innate Immunity Activated by Intermittent Metronomic Cyclophosphamide Treatment of 9L Brain Tumor Xenografts Is Preserved by Anti-Angiogenic Drugs That Spare VEGF Receptor 2

Targeting Tumor-Related Immunosuppression Using Metronomic Cyclophosphamide in Combination With Lenalidomide -New Mechanisms for Old Drugs

Toll-Like Receptors 2 and 9 Are Important for Innate Immune Cell Activation and Recruitment in Hypersensitivity Pneumonitis

Caveolin-2 Deficiency Induces a Rapid Anti-Tumor Immune Response Prior to Regression of Implanted Murine Lung Carcinoma Tumors

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice With Tumoral T Lymphoblasts

Innate Immune Defects in HIV Permissive Cell Lines

523 T-Cell Cytokines (IL-17 and IFN-γ) Exacerbates Innate Immune Responses in an Organotypic Human Psoriasis Tissue Model